Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.

Source:http://linkedlifedata.com/resource/pubmed/id/18827024

Download in:

View as

General Info

PMID
18827024